Livzon Pharmaceutical

Shanghai, China Founded: 1985 • Age: 41 yrs
Manufacturer drug preparation, bulk medicines, and intermediates
Annual revenue $1.6B Latest available
Total funding - Funding intelligence
Employees 9070 Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Livzon Pharmaceutical

Livzon Pharmaceutical is a company based in Shanghai (China) founded in 1985. The company has 9,070 employees as of December 31, 2024. Livzon Pharmaceutical has completed 2 acquisitions, including Imexpharm and Livzon Group Fuzhou Fuxing Pharmaceutical. Livzon Pharmaceutical offers products and services including Injectable Drugs and Vaccines and Biologics.

  • Headquarter Shanghai, China
  • Employees 9070 as on 31 Dec, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Legal Name Livzon Pharmaceutical Group, Inc. Class A
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
    $1.6 B (USD)
    -4.96
    as on Dec 31, 2024
  • Net Profit
    $282.22 M (USD)
    5.5
    as on Dec 31, 2024
  • EBITDA
    $435.65 M (USD)
    13.92
    as on Dec 31, 2024
  • Latest Funding Round
  • Investors
  • Employee Count
    9070

    as on Dec 31, 2024

  • Investments & Acquisitions
    Imexpharm

    & 1 more

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Livzon Pharmaceutical

Livzon Pharmaceutical is a publicly listed company on the SZSE with ticker symbol 000513 in China, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: SZSE · Ticker: 000513 · Sector: Health technology · China

Products & Services of Livzon Pharmaceutical

Livzon Pharmaceutical offers a comprehensive portfolio of products and services, including Injectable Drugs and Vaccines and Biologics.

Primary

Various injectable medications, such as Aripiprazole Microspheres, are produced for therapeutic uses in healthcare settings

Vaccines and biologic products, including recombinant proteins, are developed and supplied for disease prevention and treatment

Funding Insights of Livzon Pharmaceutical

Investments & Acquisitions by Livzon Pharmaceutical

Livzon Pharmaceutical has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Imexpharm and Livzon Group Fuzhou Fuxing Pharmaceutical.

Investments
Acquisitions
Company Name Description Domain Location Founded Year Amount
Diversified generic drugs are manufactured by Imexpharm in Vietnam.
1983
API and intermediates for antibiotics and food additives are manufactured.
1979

Financial Statements - Livzon Pharmaceutical

Livzon Pharmaceutical Comparisons

+
Add Comparison
Available on Premium

Competitors of Livzon Pharmaceutical

Latest news on Livzon Pharmaceutical

Frequently Asked Questions about Livzon Pharmaceutical

Livzon Pharmaceutical was founded in 1985.

Livzon Pharmaceutical is headquartered in Shanghai, China.

Desheng Tao is the current CEO of Livzon Pharmaceutical.

As of Dec 31, 2024, the latest employee count at Livzon Pharmaceutical is 9,070.

Annual revenue of Livzon Pharmaceutical is $1.6B as on Dec 31, 2024.

Livzon Pharmaceutical was established in 1985 and is based in Shanghai, China. Operations focus on the pharmaceutical sector, where drug preparations, bulk medicines, intermediates, diagnostic reagents, and equipment are produced. A portfolio of products is maintained for gastrointestinal, cardio-cerebral-vascular, antibiotic, gonadotropic hormone, and blood and hemopoietic system applications. The company serves these areas through its manufacturing activities.

Livzon Pharmaceutical offers Injectable Drugs and Vaccines and Biologics.

Yes, Livzon Pharmaceutical is publicly traded on SZSE under the ticker symbol 000513.

Livzon Pharmaceutical has made 2 acquisitions, including Imexpharm, and Livzon Group Fuzhou Fuxing Pharmaceutical.

The ticker symbol of Livzon Pharmaceutical is 000513 on SZSE.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available